Pharmaceutical company Organon & Co. (NYSE: OGN) has reported higher revenues and adjusted earnings for the first quarter of 2024. First-quarter revenue
Earnings Summary: Organon reports financial results for Q1 2024
![Earnings Update by AlphaStreet](https://cdn.news.alphastreet.com/wp-content/uploads/2019/04/Earnings-Coverage-4.jpg)
Pharmaceutical company Organon & Co. (NYSE: OGN) has reported higher revenues and adjusted earnings for the first quarter of 2024. First-quarter revenue
After delivering a solid performance last year, UnitedHealth Group (NYSE: UNH) will be reporting first-quarter financial data next week. The healthcare conglomerate’s
After a slow start to the year, the IPO market is witnessing a rush of tech and healthcare companies seeking to go
Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the drug store chain that is expanding into a diversified healthcare provider, is on a restructuring
Healthcare conglomerate CVS Health Corporation (NYSE: CVS) announced fourth-quarter 2023 results, reporting higher revenues and adjusted earnings. December quarter adjusted profit increased
Healthcare service provider Centene Corporation (NYSE: CNC) on Tuesday announced fourth-quarter 2023 results, reporting an increase in revenues and a fall in
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a provider of pet healthcare innovation, on Monday reported higher revenues and net income for the fourth
McKesson Corporation (NYSE: MCK), a diversified healthcare service company that operates in partnership with biopharma companies, care providers, pharmacies, and governments, on
Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) announced operating results for the second quarter of 2023, reporting higher revenues and adjusted
Bio Path Holdings Inc (NASDAQ:BPTH) Q1 2023 Earnings Call dated May. 12, 2023. Corporate Participants: Will O'Connor -- Managing Director Peter H. Nielsen -- Chairman, President,
BioLife Solutions Inc (NASDAQ:BLFS) Q1 2023 Earnings Call dated May. 10, 2023. Corporate Participants: Troy Wichterman -- Chief Financial Officer Michael Rice -- Chairman & Chief
McKesson Corporation (NYSE:MCK) Q4 2023 Earnings Call dated May. 08, 2023. Corporate Participants: Nicole Kramer -- Manager of Investor Relations Brian Tyler -- Chief Executive Officer
GoHealth Inc (NASDAQ:GOCO) Q1 2023 Earnings Call dated May. 08, 2023. Corporate Participants: John Shave -- Vice President of Investor Relations Vijay Kotte -- Chief Executive
Cigna Corporation (NYSE:CI) Q1 2023 Earnings Call dated May. 05, 2023. Corporate Participants: Ralph Giacobbe -- Senior Vice President & Head of Investor Relations
ImmunoGen Inc (NASDAQ:IMGN) Q1 2023 Earnings Call dated Apr. 28, 2023. Corporate Participants: Anabel Chan -- Head, Investor Relations Mark Enyedy -- President & Chief Executive
Edwards Lifesciences Corporation (NYSE: EW) Q1 2023 earnings call dated Apr. 26, 2023 Corporate Participants: Mark Wilterding -- Senior Vice President, Investor Relations and
Biogen Inc (NASDAQ:BIIB) Q1 2023 Earnings Call dated Apr. 25, 2023. Corporate Participants: Chuck Triano -- Head of Investor Relations Christopher Viehbacher -- President and Chief
Abbott Laboratories (NYSE: ABT) Q1 2023 earnings call dated Apr. 19, 2023 Corporate Participants: Scott Leinenweber -- Vice President, Investor Relations, Licensing and Acquisitions
Intuitive Surgical Inc (NASDAQ:ISRG) Q1 2023 Earnings Call dated Apr. 18, 2023. Corporate Participants: Brian King -- Treasurer and Head of Investor Relations Gary
Neogen Corporation (NASDAQ: NEOG) Q3 2023 earnings call dated Mar. 30, 2023 Corporate Participants: Bill Waelke -- Vice President, Investor Relations John Adent -- Chief Executive
Advanced Micro Devices Inc (NASDAQ:AMD) Q4 2022 Earnings Call dated Jan. 31, 2023. Corporate Participants: Ruth Cotter -- Senior Vice President, Worldwide Marketing, Human